Publicaciones
-
Mateo-Lozano S.
Aprataxin Tumor Levels Predict Response of Colorectal Cancer Patients to Irinotecan-based Treatment
CLINICAL CANCER RESEARCH . 16(8): 2375-2382. Nº de citas: 35
-
Tirado, OM, MacCarthy, CM, Fatima, N, Villar, J, Mateo-Lozano S and Notario, V.
Caveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewing's sarcoma cells by modulating PKC alpha phosphorylation
INTERNATIONAL JOURNAL OF CANCER . 126(2): 426-436. Nº de citas: 43
-
Mateo-Lozano S.
The Receptor Tyrosine Kinase EPHB4 Has Tumor Suppressor Activities in Intestinal Tumorigenesis
CANCER RESEARCH . 69(18): 7430-7438. Nº de citas: 55
-
Mateo-Lozano S.
Pyrazolo[1,5-a]-1,3,5-triazine as a Purine Bioisostere: Access to Potent Cyclin-Dependent Kinase Inhibitor (R)-Roscovitine Analogue
JOURNAL OF MEDICINAL CHEMISTRY . 52(3): 655-663. Nº de citas: 78
-
Bettayeb K, Tirado OM, Marionneau-Lambot S, Ferandin Y, Lozach O, Morris JC, Mateo-Lozano S, Drueckes P, Schächtele C, Kubbutat MH, Liger F, Marquet B, Joseph B, Echalier A, Endicott JA, Notario V and Meijer L.
Meriolins, a new class of cell death-inducing kinase inhibitors with enhanced selectivity for cyclin-dependent kinases
CANCER RESEARCH . 67(17): 8325-8334. Nº de citas: 111
-
Mateo-Lozano S, Gokhale PC, Soldatenkov VA, Dritschilo A, Tirado OM and Notario V.
Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma
CLINICAL CANCER RESEARCH . 12(22): 6781-6790. Nº de citas: 49
-
Tirado OM, Mateo-Lozano S, Villar J, Dettin LE, Llort A, Gallego S, Ban J, Kovar H and Notario V.
Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.
CANCER RESEARCH . 66(20): 9937-9947. Nº de citas: 113
-
Tirado OM, Mateo-Lozano S and Notario V.
Roscovitine is an effective inducer of apoptosis of Ewing's sarcoma family tumor cells in vitro and in vivo
CANCER RESEARCH . 65(20): 9320-9327. Nº de citas: 56
-
Tirado OM, Mateo-Lozano S and Notario V.
Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax: Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity
Oncogene . 24(20): 3348-3357. Nº de citas: 67
-
Mateo-Lozano S, Tirado OM and Notario V.
Rapamycin induces the fusion-type independent downregulation of the EWS/FLI-1 proteins and inhibits Ewing's sarcoma cell proliferation
Oncogene . 22(58): 9282-9287. Nº de citas: 96